VacciNEWS – Page 34 – Global Health Press

GHP News Latest Science

Recent action by Secretary of Health Robert F. Kennedy Jr. regarding ACIP

At the top of this week’s vaccine news, Secretary Robert F. Kennedy Jr. has taken the unprecedented step of dismissing all current members of the Advisory Committee on Immunization Practices (ACIP, The USA-NITAG). This...

12 June, 2025

3 min read

GHP News Latest Science

Current status of global polio eradication (June 2025)

The world stands at a critical juncture in the fight against polio. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, polio cases have been reduced by over 99.9%, saving millions from paralysis...

4 June, 2025

3 min read

New vaccine strategy could mean one-and-done for most viruses, rather than endless annual boosters targeting different viral strains. Credit: Aleya Spielman/UCLA Health

GHP News Latest Science

Moderna faces new hurdles as vaccine policy shifts

Moderna, once celebrated for its rapid development of a lifesaving COVID-19 vaccine during the initial Trump administration, now finds itself navigating a dramatically changed landscape as the U.S. government tightens...

4 June, 2025

2 min read

GHP News Latest Science

Breakthrough trans-amplifying mRNA vaccine promises broad, efficient COVID-19 immunity

A study published by Gontu et al. offers a powerful proof-of-concept for a next-generation mRNA vaccine platform that combines dose efficiency, cross-variant protection, and modular design. If validated in clinical...

4 June, 2025

4 min read

GHP News Latest Science

Moderna voluntarily withdraws BLA for Flu/COVID combination vaccine, plans resubmission later in 2025

On May 21, 2025, Moderna, announced a significant update regarding its flu/COVID combination vaccine candidate, mRNA-1083. In consultation with the U.S. Food and Drug Administration (FDA), Moderna has voluntarily...

27 May, 2025

2 min read

GHP News Latest Science

Novavax COVID-19 vaccine gains FDA approval for at-risk populations: Key details for clinicians and researchers

Novavax announced a significant regulatory milestone: the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™, its recombinant protein-based, non-mRNA COVID-19...

27 May, 2025

3 min read

GHP News Latest Science

FDA, EMA and WHO guidance on updating COVID-19 vaccines for winter 2025/26

As the northern hemisphere prepares for the 2025/26 respiratory virus season, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as well as the World Health Organization (WHO)...

27 May, 2025

4 min read

GHP News Latest Science

The future of protein-based vaccines: Why mRNA is transforming the landscape, but all platforms remain essential

The rapid evolution of vaccine technology, driven by the unprecedented success of mRNA platforms during the COVID-19 pandemic, has fundamentally shifted our approach to protein-based vaccines. mRNA vaccines offer a...

27 May, 2025

4 min read

All Articles